AngioDynamics, Inc. (ANGO) - Full Takeover Company Value

The price history of AngioDynamics, Inc. (ANGO) reflects the business valuation, which currently stands at 492.35. The catheter manufacturer's profitability relies on government procurement for scheduled procedures, cost optimization efficiency, and FDA certifications. The company's stability is supported by the neutral status of biomedicine, which eliminates the impact of sanctions. High barriers to entry are ensured by patent protection and physician preference for specific equipment.

Enterprise Value (EV) combines market capitalization and net debt, allowing for an assessment of the actual costs of acquiring a business inclusive of all liabilities. By analyzing the enterprise value trend, an investor can see how margin stabilization driven by NanoKnife and the asset restructuring of AngioDynamics, Inc. (ANGO) reduces the company's vulnerability to shocks, turning the current valuation into an indicator of fundamental resilience.